Patents by Inventor Cecile-Marie D. D. Denis

Cecile-Marie D. D. Denis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human and murine Mus81 proteins
    Patent number: 7479541
    Abstract: The present invention encompasses novel mammalian cell cycle checkpoint genes/DNA repair genes, cDNA or genomic DNA, isolated nucleic acids corresponding thereto, proteins encoded thereby, expression vectors comprising said nucleic acids, host cells transformed with said expression vectors, and methods for treating a cell using such nucleic acids or proteins.
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: January 20, 2009
    Assignees: The Scripps Research Institute, Janssen Pharmaceutica N.V.
    Inventors: Paul R. Russell, Jorge E. Vialard, Michael N. Boddy, Paul A. Shanahan, Antonia Lopez-Girona, Cecile-Marie D. D. Denis, Clare H. McGowan
  • Genes and proteins encoded thereby
    Patent number: 7214790
    Abstract: The present invention encompasses novel mammalian cell cycle checkpoint genes/DNA repair genes, cDNA or genomic DNA, isolated nucleic acids corresponding thereto, expression vectors comprising said nucleic acids, host cells transformed with said expression vectors, pharmaceutical compositions and the formulation of such compositions comprising said nucleic acids or proteins expressed therefrom, methods for treating a cell using such nucleic acids, proteins or pharmaceutical compositions, and the use of such nucleic acids or proteins in formulating a pharmaceutical preparation.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: May 8, 2007
    Assignees: The Scripps Research Institute, Janssen Pharmaceutica N.V.
    Inventors: Paul R. Russell, Jorge E. Vialard, Michael N. Boddy, Paul A. Shanahan, Antonia Lopez-Girona, Cecile-Marie D. D. Denis, Clare H. McGowan
  • Genes and proteins encoded thereby
    Patent number: 6440732
    Abstract: The present invention encompasses novel mammalian cell cycle checkpoint genes/DNA repair genes, cDNA or genomic DNA, isolated nucleic acids corresponding thereto, expression vectors comprising said nucleic acids, host cells transformed with said expression vectors, pharmaceutical compositions and the formulation of such compositions comprising said nucleic acids or proteins expressed therefrom, methods for treating a cell using such nucleic acids, proteins or pharmaceutical compositions, and the use of such nucleic acids or proteins in formulating a pharmaceutical preparation.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: August 27, 2002
    Assignees: The Scripps Research Institute, Janssen Pharmaceutica N.V.
    Inventors: Paul R. Russell, Jorge E. Vialard, Michael N. Boddy, Paul A. Shanahan, Antonia Lopez-Girona, Cecile-Marie D. D. Denis